Precursor central memory versus effector cell fate and naïve CD4+ T cell heterogeneity
Journal of Experimental Medicine · 2024
DOI: 10.1084/jem.20231193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2024. Verfasst von Deeksha Deep und 14 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Program, Memorial Sloan Kettering Cancer Center , New York, NY, USA. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Cell Differentiation, Immunologic Memory, Memory T Cells. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Upon antigenic stimulation, naïve CD4+ T cells can give rise to phenotypically distinct effector T helper cells and long-lived memory T cells. We computationally reconstructed the in vivo trajectory of CD4+ T cell differentiation during a type I inflammatory immune response and identified two distinct differentiation paths for effector and precursor central memory T cells arising directly from naïve CD4+ T cells. Unexpectedly, our studies revealed heterogeneity among naïve CD4+ T cells, which are typically considered homogeneous save for their diverse T cell receptor usage. Specifically, a previously unappreciated population of naïve CD4+ T cells sensing environmental type I IFN exhibited distinct activation thresholds, suggesting that naïve CD4+ T cell differentiation potential may be influenced by environmental cues. This population was expanded in human viral infection and type I IFN response-lined autoimmunity. Understanding the relevance of naïve T cell heterogeneity to beneficial and maladaptive T cell responses may have therapeutic implications for adoptive T cell therapies in cancer immunotherapy and vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Immunology Program, Memorial Sloan Kettering Cancer Center , New York, NY, USA.
- Tri-Institutional MD-PhD Program, Weill Cornell Medicine, The Rockefeller University and Memorial Sloan Kettering Cancer Center , New York, NY, USA.
- Immunology and Microbial Pathogenesis Program, Weill Cornell Medicine Graduate School of Medical Sciences , New York, NY, USA.
- Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center , New York, NY, USA.
- Immuno-Oncology, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center , New York, NY, USA.
- Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
ORCID-Profile: Deeksha Deep, Herman Gudjonson, Chrysothemis C Brown, Samuel A Rose, Roshan Sharma, Yoselin A Paucar Iza, Seunghee Hong, Saskia Hemmers, Michail Schizas, Zhong-Min Wang, Yuezhou Chen, Duane R Wesemann, Virginia Pascual, Dana Pe'er, Alexander Y Rudensky
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- NCI NIH HHS
- NIH HHS
- National Institute of Allergy and Infectious Diseases
- Wellcome Trust
- Memorial Sloan Kettering
- Weill Cornell
Zitieren
APA
Deep, D., Gudjonson, H., Brown, C. C., Rose, S. A., Sharma, R., Paucar Iza, Y. A., Hong, S., Hemmers, S., Schizas, M., Wang, Z. M., Chen, Y., Wesemann, D. R., Pascual, V., Pe'er, D., & Rudensky, A. Y. (2024). Precursor central memory versus effector cell fate and naïve CD4+ T cell heterogeneity. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20231193
Vancouver
Deep D, Gudjonson H, Brown CC, Rose SA, Sharma R, Paucar Iza YA, et al. Precursor central memory versus effector cell fate and naïve CD4+ T cell heterogeneity. Journal of Experimental Medicine. 2024. doi:10.1084/jem.20231193
BibTeX
@article{Deep2024,
author = {Deep, Deeksha and Gudjonson, Herman and Brown, Chrysothemis C and Rose, Samuel A and Sharma, Roshan and Paucar Iza, Yoselin A and Hong, Seunghee and Hemmers, Saskia and Schizas, Michail and Wang, Zhong-Min and Chen, Yuezhou and Wesemann, Duane R and Pascual, Virginia and Pe'er, Dana and Rudensky, Alexander Y},
title = {Precursor central memory versus effector cell fate and naïve CD4+ T cell heterogeneity},
journal = {Journal of Experimental Medicine},
year = {2024},
doi = {10.1084/jem.20231193}
}
EUVIMED